Start

Secondary Erythrocytosis in Patients Treated with a Tyrosine Kinase Inhibitor (TKI)

Specialty:

Allergy, Immunology, Anesthesiology, Cardiology, Dermatology, Endocrinology, Diabetes, Metabolism, Emergency Medicine, Family, General Practice, Geriatrics, Internal Medicine, Medical Genetics, Neurological Surgery, Neurology, Obstetrics, Gynecology, Oncology, Ophthalmology, Orthopedics, Otolaryngology, Pathology, Pediatrics, Physical Medicine and Rehabilitation, Plastic Surgery, Preventive Medicine, Psychiatry, Radiology, Surgery, Urology, Other

Objective:

ICD-10:

Description:

Alexandrescu et al reported secondary erythrocytosis in oncology patients treated with tyrosine kinase inhibitors (TKI). The authors are from Georgetown University, Washington Hospital Center, the Mayo Clinic, and Group Health in Seattle, Washington.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone